版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
GlomerularDisease
Conception
Bilateralkidneysareinvolvedinglomerulardisease.Thediseaseiscategorizedinto:Primarydisease:onlyrenalabnormalitySecondarydisease:resultingfromasystemicdisease(SLE,DM).Hereditarydisease:causedbytheabnormalityofhereditarygeneClinicalclassificationofprimaryglomerulardisease1.a(chǎn)cuteglomerulonephritis2.a(chǎn)cuterapidlyprogressiveglomerulonephritis3.chronicglomerulonephritis4.latentglomerulonephritis5.nephroticsyndromeHistologicclassification
ofprimaryglomerulardisease(byWHO)
minorglomerularabnormalitiesfocalsegmentallesions(focalsegmentalglomerulonephritis,focalsegmentalglomerularsclerosisdiffuseglomerulonephritismembranousnephropathyproliferativeglomerulonephritisMesangialproliferativeglomerulonephritisEndocapillaryproliferariveglomerulonephritisMesangialcapillaryglomerulonephritisdensedepositglomerulonephritiscrescenticglomerulonephritissclerosingglomerulonephritisglomerulonephritishavingnotbeenclassifiedPathogenesis1.thedisorderofhumoralimmunityandcellularimmunitywhichcausetheinflammationofkidneys.Pathogenesis2.withtheprogressionofthedisease,someglomeruliaredamaged,thencompensatoryhyperfiltrationandhypertrophyoftheremainingglomerulioccur,whichleadtoglomerulosclerosis.CommonsymptomsofglomerulardiseaseProteinuriaHematuriaEdemaHypertensionRenalinsufficiencyProteinuriaproteinintheurine:>150mg/24hoursor≥(+)Glomerularfilteredbarrierinjury:size-selectivebarriercharge-selectivebarrierHematuria
Whatishematuria?
>3redcells/HP.
PainlessandtotalhematuriaProteinuriaandcastsdismorphicredcellsEdema
(Saltandwaterretention)Nephritisedema;NephroticedemaHypertentionSaltandwaterretentionvolumeoverloadHyperreninemicstates(RAASactiation)ExogenouserythropoietinadministrationDecreaseofantihypertensionsubstanceNephroticSyndromeClinicalmanifestation1.heavyproteinuria:>3.5g/d2.hypoalbuminemia:<30g/L3.edema4.hyperlipidemia
Categorization:primaryandsecondaryNS.Inthesechapter,primaryNSisdiscussed.isessentialforNSPathophysiologyofnephroticsymdromheavyproteinuriaThedamageofsize-selectivebarrierand/orcharge-selectivebarrieroftheglomerularfiltrationbarrier.adecreaseofserumproteinlose:alargeamountofproteinislostthroughurineDecompositiondecomposedbytheepithelialofproximaltubule.synthesis:whentheliversynthesiscannotcompensatetheloseanddecompositionofprotein,thenhypoproteinemiaoccur.inadequateintakeofproteinmayalsoleadtohypoproteinuria.edemahypoalbuminemia→colloidosmoticpressure↓→watersmovingfromcapillarytotissueSodiumretentionHyperlipidemia(hypercholestrolemia,hypertriglyceridemiaandlowdensitylipoproteins(LDL)
Thisisbecausethesynthesisofproteinbytheliverincreaseandthedecompositionofproteindecrease.EtiologyInpatientswithdifferentages,themostcommondiseaseare:InprimaryNS:children:minimalchangediseaseSenilepatient:membranousnephropathyAdolescentpatient:mesangialproliferativeglomerulonephritismesangialcapillaryglomerulonephritisfocalsegmentalglomerularsclerosisInsecondarydiseaseChildren:congenitalnephroticsyndromeanaphylactoidpurpurahepatitisBvirusassociatednephritis.YoungpatientslupusnephritisanaphylactoidpurpurahepatitisBvirusassociatednephritis.Senilepatients:diabeticnephropathymultiplemyeloma.
DifferentialDiagnosisNephritisresultfromanaphylactoidpurpura.
palpablepurpura,arthralgias,andabdominalsymptomssuchasnausea,colic,andmelena.lupusnephritisarthralgias,skinlesions(butterfly,discoidrash),etc.ANA+,DsDNA+,C3↓Diabetesnephropathy:inadultsoccuraftermorethan10yearsofdiabetes.WhenNSoccur,itprogresstorenalfailurerelativelyquickly.DifferentialDiagnosisAmyloidosis:
insenilepatients.Manyorganscanbeinvolved.biggerkidneythannormal.Renalbiopsyisthediagnosticway.multiplemyeloma.adults,amalepredominance.bonepaininthelowerbackmonoclonalparaproteinbyserumorurinemalignantplasmacellsinbonemarrowHistologictypeandit’sclinicalfeatures
minimalchangediseasemesangialproliferativeglomerulonephritismesangialcappilaryglomerulonephritismembranousnephropathyFocalsegmentalglomerularsclerosisMinimalchangedisease(MCD)
histologicalterations
lightmicroscopy:
noglomerularlesions,lipidresorptiondropletsintubularepithelialcellselectronmicroscopy
anextensivefootprocesseffacementimmunofluorescencemicroscopy:negative
微小病變型Figure1.minimalchangedisease.Left:normalglomeruleright:abnormalglomerule.1.anextensivefootprocesseffacement2.basementmembrane3.endothelialcell4.mesangialcellminimalchangedisease微小病變型腎病綜合征。腎小球毛細(xì)血管壁呈典型的腎病綜合征改變:彌漫足突(FP)融合。尿腔內(nèi)微絨毛(MV)形成,足細(xì)胞(P)水腫,內(nèi)皮細(xì)胞(En)輕度腫脹。EMx17000Clinicalfeatures:mostcommonlyseeninchildren,accountingfor70-90%ofNSinchildren.Itcanalsobeseeninadults,particularlyinsenilepatient.hematuria:about10%-20%,nomacroscopichematuria.atransienthypertensionsensitivetosteroidsmesangialploliferativeglomerulonephritis
Histologicalterationslightmicroscopy:
mesangialhypercellularityandincreaseofmatrix.Itcanbedividedintomild,moderate,severealterations.immunofluorescencemicroscopy:
IgAnephropathynonIgAnephropathyelectronmicroscopy:
mesangialelectron-densedeposit
Figure2:mesangialploliferativeglomerulonephritis
Left:normalglomeruleright:abnormalglomerule.1.Epithelialcell2.basementmembrane3.endothelialcell4.mesangialcell5.immunecomplexmildploliferationmoderateploliferationsevereploliferation免疫熒光:IgG系膜區(qū)沉積系膜增生性腎小球腎炎。顯示系膜增生和散在的沉積物(D)。EMx7000clinicalfeatureahighincidence,commonlyseeninadolescent,dromalinfectioncanbeseen.hematuria:100%inIgAnephropathy,about70%innon-IgAnephropathy.sensitivetosteroidandcytotoxicdrugs,butcloselyassociatedwithseverityofhistologiclesions.mesangialcapillaryploliferativeglomerulonephritis(membran-oproliferativeglomerulonephritis)
histologicalterationslightmicroscopy:
endocapillaryhypercellularity,themesangialhypercellurarityandincreaseofmatrixwhichcaninsertbetweenendothelialandbasementmembraneandthenadoubletracksisformed.immunofluorescencemicroscopy:
mainlythedepositionofC3andIgG.Electronmicroscopy
electron-densedepositinmesangiumandalongcapillarywallcanbeseen.Figure2:mesangialcapillaryglomerulonephritis
Left:normalglomeruleright:abnormalglomerule.1.Epithelialcell2.basementmembrane3.endothelialcell4.mesangialcell5.immunecomplex6.basementmembranematerialalike.左為系膜毛細(xì)血管性腎炎,右為正常腎小球系膜毛細(xì)血管性腎小球腎炎(I型)。腎小球系膜區(qū)增寬,毛細(xì)血管壁增厚,局部雙軌形成。PASx260doubletracksclinicalfeaturecommonlyseeninadults,amaleprevalence.hematuria:
allexhibithematuria,macroscopichematuriaiscommon.serumC3↓anddonotrecovertonormal
clinicalfeaturerenalfunctionfailure,hypertensionandanemiaappearsearly.onlyapartofchildrenrespondtosteroidsandcytotoxicdrugs,theremainsdonotrespondwell.
membranousnephropathyhistologicalterations
lightmicroscopy:
aspikepattern,basementmembranethickenesswithoutinflammatorychanges.Electronmicroscopy:
densedepositsalongthesubepithelialsurfaceofthebasementmembrane.Spikesandeffacementoffootprocesscanbeseen.immunofluorescencemicroscopy:
IgGandC3alongcapillaryloopsFigure4:membranousnephropathy
Left:normalglomeruleright:abnormalglomerule.
1.Epithelialcell2.basementmembrane3.endothelialcell4.mesangialcell5.immunecomplexclinicalfeatures
commonlyseeninadults,amalepredominance,commonlyintheirfifthandsixthdecades.occurindolentlydevelopslowly:often5-10years→renalfailureclinicalfeatures
patientsarepronetothrombosisandthromboembolism.25%mayhaveacompletelyspontaneousremission.Beforeappearanceofspikes,patientsaresensitivetosteroidsandcytotoxicdrugs.Afterspikesappears,patientsdonotrespondtotreatmentwell.focalsegmentalsclerosis
histologicalterations
lightmicroscopy:
Focalandsegmentalglomerularsclerosis.Electronmicroscopy:Densedepositsalongthesubendothelialsurfaceofthebasementmembrane.effacementoffootprocesscanbeseen.immunofluorescencemicroscopy:
StainingofIgMandC3canbeseeninthelesionsites.
局灶節(jié)段性腎小球硬化Focalandsegmentalglomerularsclerosisclinicalfeatures
commonlyseeninadolescencedeveloplatently.hematuria:oftenseen,20%exhibitmacroscopichematuria.Oftenproximaltubulardysfunction:glucose,aminoacidinurineDosenotrespondtosteroidandcytotoxicdrugswell.Onlyasmallpartofpatientsaresensitivetothetreatment.ComplicationofNSsusceptibilitytoinfectionCause:proteinmalnutrition,immunitydysfunction,administrationwithsteroids.Infectionseencommonly:respiratorytract,urinarytractinfectionandperitonitis,etc.ItwillinfluencetheeffectoftreatmentorleadtorelapseofNS.
Thrombosisandthromboembolism
cause:ImbalanceofCoagulationandanticoagulationsystem.increasedplateletactivationbloodviscositysteroidspromptthehypercoagulationstate.
Renalveinthrombosisandothervenousthromboemboli.acuterenalfailure
Cause:colloidosmoticpressure↓→hypovolemia→renalhypoperfusion→prerenalazotemiathetubulepressedbyextremeedemaoftheinterstitium.thetubulebeingblockedbyalargeamountofproteincastwhichleadtoadecreaseofGFR.
metabolicdisturbanceofproteinandlipidDiagnosisanddifferentialdiagnosis
Diagnosis:includingisitNS?Yesorno.Yes,thenIsitprimaryNS?PrimaryNS,thenwhatkindofglomerulardisease?Histologictype.Aretherecomplications?Treatment1.diet:Protein:0.8~1.0g/(kg·d),Sodiumrestriction:2.Edema:
dietarysaltrestrictiondiuretictherapy:thiazideandloopdiureticsTreatment3.ReducingproteinuriaACEI
machanism:
loweringefferentarteriolarresistanceoutofproportiontoafferentarteriolarresistance→reducingglomerularcapillarypressureandloweringurinaryproteinexcretion.
Sideeffect:
worseningrenalfailureandhyperkalemia.4maintreatmentGlucocorticoid:
inhibitinginflammatoryreactionandimmunereaction,thesecretionofaldosteroneandADH↓.principle:sufficient
dosageshouldbegivenatthebeginning:prednisone1mg/(kg·d)for8-12weeks4maintreatmentGlucocorticoid:
principle:tapeslowly
tapethemedicinewithaspeedof10%ofthebeginningdoseevery1-2weeks.Whenitreach20mg/d,itisveryeasiertorelapse,themedicineshouldbetapedmoreslowly.4maintreatmentGlucocorticoid:
principle:Maintenanceofthemedicineforalongterm
10mg/doftenatleast6months.(prednisonecanbetakenoncedailyinthemorning)Sideeffectsofglucocorticoid:prolongedcorticosteroidtherapymayleadtoAlifethreateninginfectionOsteoporosisDiabetesmellitusAcceleratedatherosclerosisHypertensionGastritisorpepticulcerMentalillnessglucocorticoid:
accordingtotheresponsetoglucocorticoid,itcanbecategorizedintothreegroups:steroid-sensitiveremissionisachievedafter8~12weeksoftreatmentsteroid-dependentthediseaserelapseduringprednisonereducingsteroid-resistantnoeffectcanbeachievedafter8-12weeksoftreatment.4maintreatmentCytotoxicdrugsusedwhenpatientsaresteroid-dependentorsteroid-resistant.Generally,itisnotusedaloneorasprimarychoice.CyclophosphamideItcanbeusedorallyorbyintravenousway.Untilwhenthetotaldosereach6~8gor150mg/kg。Sideeffectsofcyclophosphamide:
BonemarrowsuppressionLivertoxicityGonadaldysfunctionLossofhairSymptomsofdigestivesystem:vomiting,nausea,abadappetite,etc.HemorrhagiccystitisCyclosporin
Applicabilityusedinrefractorynephroticsyndromeunresponsivetocorticosteroidandcyclophosphamide.Doses5mg/kg·dadministeredorallyin2divideddose.Cyclosporin
RelapseOncecyclosporineisdiscontinued,therelapseofnephrosisoccureasily.Analternativewaytothetreatmentisusinggraduallylowerdosesinordertomaintainthepatientinremission.Sideeffectsliverandkidneytoxicity,hypertension,TherapyfordifferenthistologictypeofnephroticsyndromeMinimalchangediseaseandmildmesangialproliferativeGN:
Corticosteroidisthemaintherapy.Ifthediseaseisunresponsivetothetherapyorrelapsefrequently,thencytotoxicdrugscanbeconsidered.
Membranousnephropathy:Itshouldbetreatedaggressively,Corticosteroidandcytotoxicdrugsshouldbeused.But,afterthetreatmentcourseisfinished,thesedrugsshouldnotbeusedwithabigdosefortoolongaterm.MembranousnephropathyHyperlipidemiaandhypercoagulablestateshouldbecontrolledtopreventthrombosisandthromboembolism.focalsegmentalglomerularsclerosis,severemesangialproliferativeglomerulonephritis,mesangialcapillaryglomerulonephritisIfrenaldysfunctionhasoccurred,thenusuallycorticosteroidandcytotoxicdrugsarenotgiven.focalsegmentalglomerularsclerosis,severemesangialproliferativeglomerulonephritis,mesangialcapillaryglomerulonephritisIfrenalfunctionisnormal,sufficientdoseofcorticosteroidandcytotoxicdrugsshouldbegivenandthentapeslowly,anddrugsforanti-coagulationandanti-aggregationofplateletscanbeadministersimultaneously.Treatmentforcomplicationinfection:
antimicrobialsensitiveforpathogenandwithoutnephrotoxicityshouldbegivenpromptly.Thrombosisandthromboembolism.ALB<20g/L,patientscanbecomehypercoagulable.
drugsHeparinasmalldoseofaspirin
thrombosistreatmentthrombolytictherapy(bestusedwithin6hours,itisprobablyeffectivewithin3days.)streptokinasecanbeused.Acuterenalfailure
abigdoseofloopdiureticshemodialysisalkalizingtheurinemetabolicdisturbanceofproteinandlipidACEIcanalleviateproteinuriaAntihyperlipidemia:HMC-CoAreductaseinhibitorsPrognosisFactorsthataffecttheprognosishistologictypeClinicalpresentations:heavyproteinuria,hypertension,hyperlipidimia,anemia,plicationTotakehomepointsTalkingaboutthenephroticsymdrom(NS).WhatisclinicalthoughofNS.
WhatisHistologictypeofNSandit’sclinicalfeatures?TotakehomepointsTalkingaboutthecomplicationofNS?TalkingabouttheapplicationofglucocorticoidinNSandit’sSideeffects.Chronicglomerulonephritis
PanLing
Conception:
Chronicglomerulonephritisreferstoagroupofglomerulardiseasethatdevelopslowlyandeventuallyleadtochronicrenalfailure.Mechanism1.
Immune-mediated
inflammatoryreaction2.Non-immuneornon-inflammatoryfactors3.AcuteChronic
immunecomplexinsitu
circulatingimmunecomplexesHistologicalterationsMesangialproliferativeglomerulonephritisMesangialcapillaryglomerulonephritisMembranousnephropathyFocalsegmentalglomerularsclerosisSclerosingglomerulonephritis
Mesangialproliferative
glomerulonephritis
Mesangialcapillary
glomerulonephritisMembranousNephropathy
Focalsegmental
glomerulosclerosis
SclerosingglomerulonephritisDiffuseinfiltrationofneutrophilininterstitumClinicalmanifestationsandlaboratoryfindingsCommonlyseeninadults,amalepredominance.Generallyoccurindolently.Somepatientspresentasacutenephriticsymdromewithprodromalinfection.(MSPGN.MPGN)Clinicalpresentations
ProteinuriaHematuriaEdemaHypertensionRenalinsufficiencyClinicalpresentations
Proteinuria:A.1~3g/d.B.Glomerularproteinuriacause:abnormalitiesintheglomerularfiltrationbarriercharacteristic:bigormiddlemolecularproteinClinicalpresentations
Hematuria:A.GlomerularhematuriaPainlessandtotalhematuriaProteinuriaandcastsphasecontrast
microscopy:multiformity
typeandmixedtype
RBCinurineincreased>80%;Acanthoiderythrocytes>5%EVDC:asymmetricalcurve
棘形RBCClinicalpresentations
Edema--Nephritisedeman(morning,eyelid,face)
glomerulotubularimbalanceeGFR↓capillarypermeability↑RAAS↓ADH↓Clinicalpresentations
Hematuria:B.Mainlyinpatientswithproliferativeorfocalhistologicalterations→itcanbemacroscopichematuriaClinicalpresentations
HypertensionSaltandwaterretentionvolumeoverloadHyperreninemicstates(RAASactiation)ExogenouserythropoietinadministrationDecreaseofantihypertensionsubstanceHBP
Clinicalpresentations
Renalinsufficiency---DifferentdegreeSerumcreatinine↑
Ccr↓eGFR↓UrinevolumeabnormalChronicprogressionofthediseaseisassociatedwith:
HistologictypeTherapycondition.Theexistofworseningfactors:tiredness,infection,uncontrolledhypertension,nephrotoxicdrugs.DiagnosisanddifferentialdiagnosisDiagnosis:Clinicalmanifestation:
proteinuia,hematuria,edema,hypertension,renalinsufficiency.Secondaryandhereditaryglomerulonephritisshouldbeexcluded.Course>3M,mostonsethidden,complicationBultrasound:bilateralsmallkidney
2.DifferentialdiagnosisSecondaryGN:
lupusnephritis,anaphylactoidpurprua.Alportsyndrome
commonlyseeninchildren(<10ys)abnormalityofrenal,eyesandearsexistsimultaneously.Apositivefamilyhistoryisfound.Otherprimaryglomerulonephritis
AcuteGNpostinfection:mainlyseeninchildrenprodromalsymptom:1-3weeksbeforehematuria:almost100%serumC3
,yetrecovertonormallevelwithin8weeks.Otherprimaryglomerulonephritis
AcuteGNpostinfection:histologiclesions:endocapillaryproliferativeGN
favorableprognosisinchildren,butadultsaremorepronetochronicrenalinsufficiency.Renaldamagecausedbyprimaryhypertensionrenaldamageisseenafteralongtermofhypertension.tubulardysfunctionoccurearlierthanglomerulardysfunction.Renaldamagecausedbyprimaryhypertensionotherta
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 《Q690高強(qiáng)鋼焊接截面熱-結(jié)構(gòu)耦合分析及縱向殘余應(yīng)力分布模型研究》
- 2024年城市綜合體土地租賃合作框架合同范本3篇
- 校園演講稿模板匯編九篇資料
- 排水管道選購合同
- 混凝土分項(xiàng)工程外包合同
- 人才獵聘服務(wù)合同示范
- 設(shè)備保養(yǎng)維修服務(wù)合同
- 瓷磚供貨商合同
- 婚慶服務(wù)合同詳盡匯編
- 簡化房屋交易協(xié)議
- 文旅深度融合長期發(fā)展規(guī)劃
- ASTM-D3359-(附著力測試標(biāo)準(zhǔn))-中文版
- 5 協(xié)商決定班級事務(wù) (教學(xué)設(shè)計(jì))-2024-2025學(xué)年道德與法治五年級上冊統(tǒng)編版
- 2024年清潔機(jī)器人項(xiàng)目合作計(jì)劃書
- 高校實(shí)驗(yàn)室安全通識課學(xué)習(xí)通超星期末考試答案章節(jié)答案2024年
- 銀行客戶經(jīng)理招聘面試題與參考回答(某大型集團(tuán)公司)
- 殘疾人體育活動推廣與普及考核試卷
- 《安全系統(tǒng)工程》期末考試卷及答案
- 空氣動力學(xué)仿真技術(shù):計(jì)算流體力學(xué)(CFD):CFD在飛機(jī)設(shè)計(jì)中的應(yīng)用
- 2024新教材高中政治 第一單元 生產(chǎn)資料所有制與經(jīng)濟(jì)體制 第一課 我國的生產(chǎn)資料所有制 1.1《公有制為主體 多種所有制經(jīng)濟(jì)共同發(fā)展》教案 部編版必修2
- 職業(yè)學(xué)院食品藥品監(jiān)督管理專業(yè)核心課《企業(yè)管理》課程標(biāo)準(zhǔn)
評論
0/150
提交評論